JingLuoMD

PubMed

• Buprenorphine dispensing before and after the April 2021 X-Waiver exemptions: An interrupted time series analysis.
  Payel Jhoom Roy, Katie Suda, Jing Luo, MyoungKeun Lee, Joel Anderton, Donna Olejniczak, Jane M Liebschutz> ;The International Journal on Drug Policy. 2024 Mar 7
• 2 citations
  Incidence Rates and Clinical Characteristics of Patients With Confirmed Myocarditis or Pericarditis Following COVID-19 mRNA Vaccination: Experience of the Veterans Hea...
  Jing Luo, Kwan Hur, Cedric Salone, Nina Huang, Muriel Burk, Lucy Pandey, Bharat Thakkar, Mark Donahue, Francesca Cunningham> ;Open Forum Infectious Diseases. 2023 Jul 1
• 10 citations
  Evaluation of Out-of-Pocket Costs and Treatment Intensification With an SGLT2 Inhibitor or GLP-1 RA in Patients With Type 2 Diabetes and Cardiovascular Disease.
  Jing Luo, Robert Feldman, Katherine Callaway Kim, Scott Rothenberger, Mary Korytkowski, Inmaculada Hernandez, Walid F Gellad> ;JAMA Network Open. 2023 Jun 1
• 2 citations
  Electronic Prior Authorization for Prescription Drugs - Challenges and Opportunities for Reform.
  Jing Luo, Walid F Gellad> ;The New England Journal of Medicine. 2023 Mar 9
• 4 citations
  Impact of COVID-19-related regulatory changes on nationwide access to buprenorphine: An interrupted time series design.
  Payel Jhoom Roy, Katherine Callaway Kim, Katie Suda, Jing Luo, Xiaoming Wang, Donna Olejniczak, Jane M Liebschutz> ;Drug and Alcohol Dependence Reports. 2023 Mar 1
• 5 citations
  Real-world weight-loss effectiveness of glucagon-like peptide-1 agonists among patients with type 2 diabetes: A retrospective cohort study.
  Gretchen E White, Ingrid Shu, David Rometo, Jon Arnold, Mary Korytkowski, Jing Luo> ;Obesity. 2023 Feb 1
• Where Do Real-Time Prescription Benefit Tools Fit in the Landscape of High US Prescription Medication Costs? A Narrative Review.
  Rachel Wong, Tanvi Mehta, Bradley Very, Jing Luo, Kristian Feterik, Bradley H Crotty, Jeremy A Epstein, Michael J Fliotsos, Nitu Kashyap, Erika Smith, Fasika A Woreta,...> ;Journal of General Internal Medicine. 2023 Mar 1
• 6 citations
  Downregulation of iNOS/NO Promotes Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
  Qiang Du, Silvia Liu, Kun Dong, Xiao Cui, Jing Luo, David A Geller> ;Molecular Cancer Research. 2023 Feb 1
• 2 citations
  A machine learning approach identifies modulators of heart failure hospitalization prevention among patients with type 2 diabetes: A revisit to the ACCORD trial.
  Hamed Kianmehr, Jingchuan Guo, Yilu Lin, Jing Luo, William Cushman, Lizheng Shi, Vivian Fonseca, Hui Shao> ;Journal of Diabetes and Its Complications. 2022 Sep 1
• 1 citations
  Trends in Out-of-Pocket Cost of Glucagon, 2010-2020.
  Margaret Zupa, Robert Feldman, Jing Luo> ;JAMA Network Open. 2022 Aug 1
• 3 citations
  Projected Impact of the Medicare Part D Senior Savings Model on Diabetes-Related Health and Economic Outcomes Among Insulin Users Covered by Medicare.
  Hui Shao, Dawei Guan, Jingchuan Guo, Tianze Jiao, Yongkang Zhang, Jing Luo, Lizheng Shi, Vivian Fonseca, Joshua D Brown> ;Diabetes Care. 2022 Aug 1
• 4 citations
  Association of formulary restrictions and initiation of an SGLT2i or GLP1-RA among Medicare beneficiaries with type 2 diabetes.
  Jing Luo, Nico Gabriel, Mary Korytkowski, Inmaculada Hernandez, Walid F Gellad> ;Diabetes Research and Clinical Practice. 2022 May 1
• 12 citations
  Potential Gains in Life Expectancy Associated With Achieving Treatment Goals in US Adults With Type 2 Diabetes.
  Hamed Kianmehr, Ping Zhang, Jing Luo, Jingchuan Guo, Meda E Pavkov, Kai McKeever Bullard, Edward W Gregg, Naykky Singh Ospina, Vivian Fonseca, Lizheng Shi, Hui Shao> ;JAMA Network Open. 2022 Apr 1
• 6 citations
  Incidence and Predictors of Primary Nonadherence to Sodium Glucose Co-transporter 2 Inhibitors and Glucagon-Like Peptide 1 Agonists in a Large Integrated Healthcare Sy...
  Jing Luo, Robert Feldman, Scott Rothenberger, Mary Korytkowski, Michael A Fischer, Walid F Gellad> ;Journal of General Internal Medicine. 2022 Nov 1
• 48 citations
  Racial, Ethnic, and Socioeconomic Inequities in Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Diabetes in the US.
  Lauren A Eberly, Lin Yang, Utibe R Essien, Nwamaka D Eneanya, Howard M Julien, Jing Luo, Ashwin S Nathan, Sameed Ahmed M Khatana, Elias J Dayoub, Alexander C Fanaroff,...> ;JAMA Health Forum. 2021 Dec 1
• An Unnecessary Gift for COVID-19 Vaccines and Therapeutics: The Medical Countermeasure Priority Review Voucher.
  Reshma Ramachandran, Jing Luo> ;American Journal of Public Health. 2021 Oct 14
• 1 citations
  Access to Affordable Insulin and Epinephrine Autoinjectors Through Federally Qualified Health Centers.
  Gautam Rangavajla, Walid Gellad, Jing Luo> ;JAMA Health Forum. 2021 Mar 1
• 5 citations
  Interferon Regulatory Factor-1 (IRF1) activates autophagy to promote liver ischemia/reperfusion injury by inhibiting β-catenin in mice.
  Bing Yan, Jing Luo, Christof Kaltenmeier, Qiang Du, Donna B. Stolz, Patricia Loughran, Yihe Yan, Xiao Cui, David A. Geller> ;Plos One. 2020 Nov 2
• 12 citations
  iNOS/NO is required for IRF1 activation in response to liver ischemia-reperfusion in mice.
  Qiang Du, Jing Luo, Mu-qing Yang, Quan Liu, Caroline Heres, Yihe Yan, Donna B. Stolz, David A. Geller> ;Molecular Medicine. 2020 Jun 9
• 3 citations
  MicroRNA-301a (miR-301a) is induced in hepatocellular carcinoma (HCC) and down- regulates the expression of interferon regulatory factor-1
  Kun Dong, Qiang Du, Xiao Cui, Peiqi Wan, Christof Kaltenmeier, Jing Luo, Bing Yan, Yihe Yan, David A. Geller> ;Biochemical and Biophysical Research Communications. 2020 Jan 25
• 27 citations
  Implementation of a Health Plan Program for Switching From Analogue to Human Insulin and Glycemic Control Among Medicare Beneficiaries With Type 2 Diabetes.
  Jing Luo, Nazleen F. Khan, Thomas Manetti, James Q. Rose, Ani Kaloghlian, Balu Gadhe, Sachin H. Jain, Joshua J. Gagne, Aaron S. Kesselheim> ;JAMA. 2019 Jan 29
• 16 citations
  IL-23 mediates murine liver transplantation ischemia-reperfusion injury via IFN-γ/IRF-1 pathway.
  John R. Klune, Christian Bartels, Jing Luo, Shinichiro Yokota, Qiang Du, David A. Geller> ;American Journal of Physiology. Gastrointestinal and Liver Physiology. 2018 Dec 1
• 31 citations
  miR-383 promotes cholangiocarcinoma cell proliferation, migration, and invasion through targeting IRF1.
  Peiqi Wan, Xiaojv Chi, Qiang Du, Jing Luo, Xiao Cui, Kun Dong, Yan Bing, Caroline Heres, David A. Geller> ;Journal of Cellular Biochemistry. 2018 Aug 26
• 26 citations
  Effect of Generic Competition on Atorvastatin Prescribing and Patients’ Out-of-Pocket Spending
  Jing Luo, John D. Seeger, Macarius Donneyong, Joshua J. Gagne, Jerry Avorn, Aaron S. Kesselheim> ;JAMA Internal Medicine. 2016 Sep 1
• Inaccurate Reporting of Insulin Reimbursement—Reply
  Jing Luo, Jerry Avorn, Aaron S. Kesselheim> ;JAMA Internal Medicine. 2016 Mar 1
• Join now to see all